James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the phase 3 trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.
The American Academy of Neurology awarded Monica M. Diaz, MD, MS, a Clinical Research Training Scholarship in support of her research on the detection of neurodegeneration in older, cognitively impaired people with HIV.
The Duke/UNC ADRC is pleased to announce the release of three funding opportunities for researchers at Duke and UNC studying Alzheimer’s disease and related dementias. One of the awards, the REC Scholar, is also open to candidates from UNC Pembroke, North Carolina Central University, and East Carolina University.
Over 800 scientists from across the United States and overseas convened virtually for a joint Duke/UNC Alzheimer’s Disease Symposium on May 27.
NC TraCS awarded funding for a $5K-$50K grant application submitted by Yen-Yu Ian Shih, PhD.
The UNC Department of Neurology is proud to announce that child neurologists Senyene Hunter, MD, PhD, and Diana Cejas, MD, MPH, are this year’s recipients of the UNC Broyhill Research Award in Child Neurology.
The Center for Animal MRI (CAMRI) at the Biomedical Research Imaging Center (BRIC), led by Ian Shih, PhD, received two National Institutes of Health grants totaling $2.6 million for a new MRI instrument and to upgrade an existing MRI system.
The Division of Neuromuscular Disorders has been designated as a Hereditary Neuropathy Foundation Charcot-Marie-Tooth Center of Excellence.
James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the phase 3 trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.
